Christopher P. Lowe - 24 Aug 2022 Form 4 Insider Report for Vincerx Pharma, Inc. (VINC)

Reporting relationship: Director
Issuer ticker: VINC
Reported as of: 24 Aug 2022
Net transaction value: +$49,438
SEC form: 4
Accepted by SEC: 26 Aug 2022, 16:06:10 UTC
Prior SEC filing: 31 May 2022
Source filing: View source filing
Reporting owner signature: /s/ Christopher P. Lowe

Key filing fact

Christopher P. Lowe filed Form 4 for Vincerx Pharma, Inc. (VINC) on 26 Aug 2022.

Key facts

This page summarizes Christopher P. Lowe's Form 4 filing for Vincerx Pharma, Inc. (VINC).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 26 Aug 2022, 16:06.

Change

Previous filing in this sequence was filed on 31 May 2022.
Current net transaction value: +$49,438.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VINC transaction

Common Stock

Purchase

Transaction value: $30,299
Shares: +18,400
Change %: +184%
Price: $1.65
Shares after: 28,400
Date: 24 Aug 2022
Ownership: Direct
Footnotes: F1

VINC transaction

Common Stock

Purchase

Transaction value: $19,139
Shares: +11,600
Change %: +41%
Price: $1.65
Shares after: 40,000
Date: 25 Aug 2022
Ownership: Direct
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents a weighted average purchase price. Actual purchase prices ranged from $1.638 to $1.649 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares purchased within the range indicated.

Footnote F2

Represents a weighted average purchase price. Actual purchase prices ranged from $1.6499 to $1.65 per share. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares purchased within the range indicated.